Ronald A. Matricaria
Chairman at Systems Oncology LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexis V. Lukianov | M | 68 |
Systems Oncology LLC
 Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | 15 years |
| Kieran Gallahue | M | 60 |
Systems Oncology LLC
Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | 9 years |
| Robert Courteau | M | 68 | 8 years | |
| Chris Yoo | M | - |
Systems Oncology LLC
Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | 9 years |
| Geoffrey Gillespie | M | 53 | 3 years | |
| Ehab M. Esmail | M | - | 5 years | |
| Michael Paolucci | M | 64 | 8 years | |
| Daniel Douglas von Hoff | M | 76 |
Systems Oncology LLC
Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | - |
| L. Steve Goldstein | M | - |
University of Minnesota Foundation
| - |
| Jill Denham | F | 62 | 8 years | |
| Gavin Bogle | M | - |
Systems Oncology LLC
Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | - |
| Jill Mason | F | - | 9 years | |
| Eric Kim | M | - |
Grant Avenue Capital LLC
 Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | 5 years |
| Samantha Palmerton Bonano | F | - |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | 3 years |
| Spyro Mousses | M | - |
Systems Oncology LLC
Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | - |
| Gerald B. Fischer | M | 80 |
University of Minnesota Foundation
| 34 years |
| Buddy Gumina | M | - |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | 7 years |
| James Hollingworth | M | - | 9 years | |
| Alex Ferree | M | - |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | 5 years |
| Jason Hannon | M | 52 | 4 years | |
| Shari Ballard | F | 57 |
University of Minnesota Foundation
| - |
| Angel Mendez | M | 63 | 8 years | |
| Dianne Flynn | F | - | 15 years | |
| Neil Torres | M | - |
Systems Oncology LLC
Systems Oncology LLC BiotechnologyHealth Technology Systems Oncology LLC engages in the development of cancer drug and therapies. It combines multi-scalar systems modeling with machine learning and big-data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. The company is headquartered in Scottsdale, AZ. | - |
| Martha Douglas | F | - |
University of Minnesota Foundation
| - |
| Jane Godfrey | F | - |
University of Minnesota Foundation
| - |
| Kevin Kenny | M | 58 | 5 years | |
| David A. Dripchak | M | - | 9 years | |
| Judi H. Dutcher | F | - |
University of Minnesota Foundation
| - |
| Ka Wo Wong | M | 73 |
University of Minnesota Foundation
| - |
| William Hawkins | M | 70 |
University of Minnesota Foundation
| - |
| Michael Roman | M | 64 |
University of Minnesota Foundation
| - |
| Guy Sansone | M | 59 |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | - |
| Charles M. Osborne | M | 71 |
University of Minnesota Foundation
| 24 years |
| Deborah L. Hopp | F | 71 |
University of Minnesota Foundation
| - |
| Richard Davis | M | 66 |
University of Minnesota Foundation
| - |
| Steven D. Ladwig | M | - |
University of Minnesota Foundation
| - |
| Elliot S. Kaplan | M | 87 |
University of Minnesota Foundation
| - |
| Peter C. Madeja | M | 65 |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | - |
| Richard Lindstrom | M | 76 |
University of Minnesota Foundation
| - |
| Philip Soran | M | 67 |
University of Minnesota Foundation
| 10 years |
| Nancy Wiser | F | 57 |
University of Minnesota Foundation
| 2 years |
| Teresa Sparks | F | 55 |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | - |
| Vicky Gregg | F | 69 |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | - |
| Brian S. Berkin | M | - |
Grant Avenue Capital LLC
Grant Avenue Capital LLC Investment ManagersFinance Grant Avenue Capital LLC (Grant Avenue Capital) is a private equity firm founded in 2017 by Buddy Gumina. The firm is headquartered in New York. | 2 years |
| David Meyer | M | 70 |
University of Minnesota Foundation
| - |
| Susan Marvin | F | 69 |
University of Minnesota Foundation
| 23 years |
| Nancy M. Lindahl | F | - |
University of Minnesota Foundation
| - |
| Penny Wheeler | M | 65 |
University of Minnesota Foundation
| - |
| Rich Kruger | M | 64 |
University of Minnesota Foundation
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Starks | M | 69 | 21 years | |
| Jon Serbousek | M | 63 | 4 years | |
| Michael Rousseau | M | 68 | - | |
| Catherine Burzik | F | 73 | 3 years | |
| Siddhartha Kadia | M | 54 |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 6 years |
| Kimberley Elting | F | 59 | 8 years | |
| Kathleen Regan | F | - | 1 years | |
| Darin Lippoldt | M | 58 | 4 years | |
| R. Huennekens | M | 59 | 13 years | |
| Jeffrey Michael Schumm | M | 62 | 9 years | |
| Lori Smith | F | - | - | |
| Bradley Robert Mason | M | 70 | 6 years | |
| Douglas P. Colbeth | M | 68 | 17 years | |
| Joseph Alldredge | M | - | 3 years | |
| Michael Coyle | M | 62 | 13 years | |
| John Sheridan | M | 68 | 6 years | |
| Leslie Norwalk | F | 58 | 4 years | |
| Andrew Balo | M | 76 | 7 years | |
| Douglas Rice | M | 58 | 9 years | |
| John Sicard | M | 61 | 5 years | |
| Heino von Prondzynski | M | 73 | 6 years | |
| Jim Hinrichs | M | 56 | 10 years | |
| Jeffrey A. Swiecki | M | 52 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 2 years |
| Lilly Marks | F | 76 | 8 years | |
| Scott P. Thome | M | 61 | 19 years | |
| Steven Jandrich | M | 57 | 14 years | |
| Thomas G. Moore | M | 72 | 10 years | |
| Paul Carreiro | M | - | 6 years | |
| Davey Scoon | M | 78 | 4 years | |
| Gregory Lucier | M | 59 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 5 years |
| Kevin T. O'Malley | M | 72 | - | |
| Mark F. Wheeler | M | 74 | 9 years | |
| Maria Degois Sainz | F | 58 | 9 years | |
| Kenneth R. Weisshaar | M | 73 | 10 years | |
| Kelli A. Richard | F | 55 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 3 years |
| Sumant Ramachandra | M | 55 | 7 years | |
| Guy J. Jordan | M | 75 | 13 years | |
| Terry L. Shepherd | M | - | 5 years | |
| John Heinmiller | M | 69 | 21 years | |
| Roger W. Hale | M | 80 | 9 years | |
| Anthony Francis Martin | M | 69 | 4 years | |
| Ken Meyers | M | 62 | 7 years | |
| Stuart Essig | M | 62 | 18 years | |
| Walter P. von Wartburg | M | 84 | 10 years | |
| John A. Cottingham | M | 69 |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 8 years |
| Richard R. Devenuti | M | 67 | 16 years | |
| Wendy Yarno | F | 68 | 15 years | |
| Luke Faulstick | M | 60 | 5 years | |
| Barbara Landers Bowles | F | 76 | 7 years | |
| Richard Heppenstall | M | 53 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| Canada | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald A. Matricaria
- Personal Network
